Meta has released a new AI model that combines reinforcement learning with large language models to create a more transparent and reliable insulin pump controller for Type 1 Diabetes patients. The model, called LLM-T1D, has shown promising results in blood sugar control and safety verification. This breakthrough has the potential to revolutionize the treatment of Type 1 Diabetes and improve the lives of millions of people worldwide.

LongMedBench is a new benchmark for evaluating medical agents in long-horizon clinical decision-making. It provides a realistic assessment of AI models in medical care, emphasizing longitudinal interactions and multi-session decision-making. This benchmark has significant implications for the development of more accurate and reliable medical AI systems.

MedEvoEval introduces a groundbreaking framework for evaluating AI doctor agents in simulated clinical settings. By tracking cross-episode learning and decision-making, it addresses critical gaps in medical AI evaluation. This tool enables developers to measure knowledge retention, resource allocation, and behavioral adaptation over time.

Meta researchers achieved 87.69% accuracy in predicting primary ICD-10 diagnosis categories by combining frozen medical LLM representations with multimodal EHR data. Their approach outperformed existing models and demonstrated strong cross-dataset adaptability.

OpenAI introduces IMCBench, a benchmark for multimodal large language models in image-grounded medical conversations, evaluating safety, accuracy, and uncertainty in diagnosis. The benchmark tests eight models, with Claude Opus 4.6 achieving the highest overall score. The results highlight the need for multi-dimensional evaluation frameworks in medical AI.